57 related articles for article (PubMed ID: 9699532)
21. Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.
Bacolod MD; Barany F
J Mol Diagn; 2010 Sep; 12(5):552-61. PubMed ID: 20709793
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
Tejpar S; Bertagnolli M; Bosman F; Lenz HJ; Garraway L; Waldman F; Warren R; Bild A; Collins-Brennan D; Hahn H; Harkin DP; Kennedy R; Ilyas M; Morreau H; Proutski V; Swanton C; Tomlinson I; Delorenzi M; Fiocca R; Van Cutsem E; Roth A
Oncologist; 2010; 15(4):390-404. PubMed ID: 20350999
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis: microsatellity instability and loss of heterozygosity of tumor suppressor gene in hereditary non-polyposis colorectal cancers (HNPCC).
Hadziavdić V; Pavlović-Calić N; Eminović I
Bosn J Basic Med Sci; 2009 Feb; 9(1):10-8. PubMed ID: 19284389
[TBL] [Abstract][Full Text] [Related]
24. Predictive and prognostic markers in colorectal cancer.
Wilson PM; Ladner RD; Lenz HJ
Gastrointest Cancer Res; 2007 Nov; 1(6):237-46. PubMed ID: 19262902
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer.
Hadziavdić V; Pavlović-Calić N; Eminović I
Bosn J Basic Med Sci; 2008 Nov; 8(4):313-21. PubMed ID: 19125701
[TBL] [Abstract][Full Text] [Related]
26. Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma.
Zhou CZ; Qiu GQ; Fan JW; Wang XL; Tang HM; Huang L; Sun YH; Peng ZH
World J Gastroenterol; 2008 Mar; 14(10):1582-7. PubMed ID: 18330952
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
[TBL] [Abstract][Full Text] [Related]
28. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis.
Azzoni C; Bottarelli L; Campanini N; Di Cola G; Bader G; Mazzeo A; Salvemini C; Morari S; Di Mauro D; Donadei E; Roncoroni L; Bordi C; Sarli L
Int J Colorectal Dis; 2007 Feb; 22(2):115-26. PubMed ID: 17021745
[TBL] [Abstract][Full Text] [Related]
29. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma.
Ji H; Kumm J; Zhang M; Farnam K; Salari K; Faham M; Ford JM; Davis RW
Cancer Res; 2006 Aug; 66(16):7910-9. PubMed ID: 16912164
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of additional pathological variables for long-term survival after curative resection of rectal cancer.
Krebs B; Kozelj M; Kavalar R; Gajzer B; Gadzijev EM
World J Gastroenterol; 2006 Jul; 12(28):4565-8. PubMed ID: 16874874
[TBL] [Abstract][Full Text] [Related]
31. A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer.
Erill N; Colomer A; Calvo M; Vidal A; Román R; Verdú M; Cordón-Cardó C; Puig X
J Mol Diagn; 2005 Oct; 7(4):478-85. PubMed ID: 16237217
[TBL] [Abstract][Full Text] [Related]
32. [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy].
Fernández-Cebrián JM; Vorwald Kuborn P; Pardo de Lama M; Sanjuanbenito Dehesa A; Nevado Santos M; Pacheco Martínez PA; Fernández-Escudero B
Clin Transl Oncol; 2005 Apr; 7(3):101-9. PubMed ID: 15899217
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer.
Peng Z; Zhang F; Zhou C; Ling Y; Bai S; Liu W; Qiu G; He L; Wang L; Wei D; Lin E; Xie K
Int J Gastrointest Cancer; 2003; 34(1):39-48. PubMed ID: 15235134
[TBL] [Abstract][Full Text] [Related]
34. MBD1, MBD2 and CGBP genes at chromosome 18q21 are infrequently mutated in human colon and lung cancers.
Bader S; Walker M; McQueen HA; Sellar R; Oei E; Wopereis S; Zhu Y; Peter A; Bird AP; Harrison DJ
Oncogene; 2003 May; 22(22):3506-10. PubMed ID: 12776203
[TBL] [Abstract][Full Text] [Related]
35. [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].
Baldus SE
Pathologe; 2003 Feb; 24(1):49-60. PubMed ID: 12601478
[TBL] [Abstract][Full Text] [Related]
36. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer.
Lanza G; Matteuzzi M; Gafá R; Orvieto E; Maestri I; Santini A; del Senno L
Int J Cancer; 1998 Aug; 79(4):390-5. PubMed ID: 9699532
[TBL] [Abstract][Full Text] [Related]
38. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
[TBL] [Abstract][Full Text] [Related]
39. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
[TBL] [Abstract][Full Text] [Related]
40. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
